Buttorff Leslie's Form 4 filing
Panacea Life Sciences Holdings, Inc. (PLSH) · filed Jul 12, 2022
- Accession no.
- 0001493152-22-019076
- Filed
- Jul 12, 2022, 4:05 PM ET
- Trade date
- Jul 8-11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.18K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Buttorff LeslieCIK 0001866792 | Director, Officer (CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 | Common Stock | PPurchaseAcquired | +1,600 | $0.20 | +$320 | 621,049 | Direct | |
| Jul 8, 2022 | Common Stock | PPurchaseAcquired | +2,500 | $0.155 | +$387.5 | 623,549 | Direct | |
| Jul 11, 2022 | Common Stock | PPurchaseAcquired | +1,000 | $0.3939 | +$393.9 | 624,549 | Direct | |
| Jul 11, 2022 | Common Stock | PPurchaseAcquired | +500 | $0.495 | +$247.5 | 625,049 | Direct | |
| Jul 11, 2022 | Common Stock | PPurchaseAcquired | +2,100 | $0.3979 | +$835.59 | 627,149 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.